ID

13137

Descripción

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00271063

Link

https://clinicaltrials.gov/show/NCT00271063

Palabras clave

Versiones (1)
  1. 19/1/16 19/1/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

19 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Lymphocytic Leukemia NCT00271063

Inglés

Eligibility Acute Lymphocytic Leukemia NCT00271063

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of refractory or relapsed all (acute lymphocytic leukemia)
Descripción

ALL

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023449
age greater than or equal to 15 years
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
no chemotherapy, radiation, or major surgery within 2 weeks prior to first dose of study drug and recovered from toxic side effects of that therapy, unless treatment is indicated due to progressive disease.
Descripción

chemotherapy, radiation, or major surgery

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0543467
no investigational therapy within 4 weeks of first dose of study drug
Descripción

investigational drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
ecog performance status (ps) 0 to 2.
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
adequate liver function
Descripción

liver function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232741
adequate renal function
Descripción

renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232804
signed informed consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
concommitant therapy that includes other chemotherapy that is or may be active against all (except central nervous system [cns] therapy)
Descripción

concommitant therapy that includes other chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
any condition which in the opinion of the investigator, places the subject at unacceptable risk if he/she were to participate in the study.
Descripción

condition limiting study protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
cardiac ejection fraction less than 40%
Descripción

cardiac ejection fraction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232174
clinically relevant serious co-morbid medical conditions.
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
pregnant, lactating or not using adequate contraception.
Descripción

pregnant, lactating or not using adequate contraception

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0700589
known allergy to doxorubicin or anthracyclines.
Descripción

allergy to doxorubicin or anthracyclines

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013089
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0282564
Volver a la parte superior de la página

Similar models

Eligibility Acute Lymphocytic Leukemia NCT00271063

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ALL
Item
diagnosis of refractory or relapsed all (acute lymphocytic leukemia)
boolean
C0023449 (UMLS CUI [1])
age
Item
age greater than or equal to 15 years
boolean
C0001779 (UMLS CUI [1])
chemotherapy, radiation, or major surgery
Item
no chemotherapy, radiation, or major surgery within 2 weeks prior to first dose of study drug and recovered from toxic side effects of that therapy, unless treatment is indicated due to progressive disease.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
investigational drugs
Item
no investigational therapy within 4 weeks of first dose of study drug
boolean
C0013230 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status (ps) 0 to 2.
boolean
C1520224 (UMLS CUI [1])
liver function
Item
adequate liver function
boolean
C0232741 (UMLS CUI [1])
renal function
Item
adequate renal function
boolean
C0232804 (UMLS CUI [1])
informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
concommitant therapy that includes other chemotherapy
Item
concommitant therapy that includes other chemotherapy that is or may be active against all (except central nervous system [cns] therapy)
boolean
C0392920 (UMLS CUI [1])
condition limiting study protocol
Item
any condition which in the opinion of the investigator, places the subject at unacceptable risk if he/she were to participate in the study.
boolean
C2348563 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
cardiac ejection fraction
Item
cardiac ejection fraction less than 40%
boolean
C0232174 (UMLS CUI [1])
comorbidity
Item
clinically relevant serious co-morbid medical conditions.
boolean
C0009488 (UMLS CUI [1])
pregnant, lactating or not using adequate contraception
Item
pregnant, lactating or not using adequate contraception.
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
allergy to doxorubicin or anthracyclines
Item
known allergy to doxorubicin or anthracyclines.
boolean
C0020517 (UMLS CUI [1,1])
C0013089 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0282564 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial